3.25.2 html 230 235 1 false 52 0 false 9 false false R1.htm 0000001 - Document - Cover Sheet http://c4therapeutics.com/role/Cover Cover Cover 1 false false R2.htm 9952151 - Statement - Condensed Consolidated Balance Sheets Sheet http://c4therapeutics.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 9952152 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://c4therapeutics.com/role/CondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 9952153 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss Sheet http://c4therapeutics.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss Condensed Consolidated Statements of Operations and Comprehensive Loss Statements 4 false false R5.htm 9952154 - Statement - Condensed Consolidated Statements of Stockholders??? Equity Sheet http://c4therapeutics.com/role/CondensedConsolidatedStatementsofStockholdersEquity Condensed Consolidated Statements of Stockholders??? Equity Statements 5 false false R6.htm 9952155 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://c4therapeutics.com/role/CondensedConsolidatedStatementsofCashFlows Condensed Consolidated Statements of Cash Flows Statements 6 false false R7.htm 9952156 - Disclosure - Nature of the business and basis of presentation Sheet http://c4therapeutics.com/role/Natureofthebusinessandbasisofpresentation Nature of the business and basis of presentation Notes 7 false false R8.htm 9952157 - Disclosure - Summary of significant accounting policies Sheet http://c4therapeutics.com/role/Summaryofsignificantaccountingpolicies Summary of significant accounting policies Notes 8 false false R9.htm 9952158 - Disclosure - Fair value measurements Sheet http://c4therapeutics.com/role/Fairvaluemeasurements Fair value measurements Notes 9 false false R10.htm 9952159 - Disclosure - Marketable securities Sheet http://c4therapeutics.com/role/Marketablesecurities Marketable securities Notes 10 false false R11.htm 9952160 - Disclosure - Property and equipment Sheet http://c4therapeutics.com/role/Propertyandequipment Property and equipment Notes 11 false false R12.htm 9952161 - Disclosure - Accrued expenses and other current liabilities Sheet http://c4therapeutics.com/role/Accruedexpensesandothercurrentliabilities Accrued expenses and other current liabilities Notes 12 false false R13.htm 9952162 - Disclosure - Collaboration and license agreements Sheet http://c4therapeutics.com/role/Collaborationandlicenseagreements Collaboration and license agreements Notes 13 false false R14.htm 9952163 - Disclosure - Stockholders equity Sheet http://c4therapeutics.com/role/Stockholdersequity Stockholders equity Notes 14 false false R15.htm 9952164 - Disclosure - Stock-based compensation Sheet http://c4therapeutics.com/role/Stockbasedcompensation Stock-based compensation Notes 15 false false R16.htm 9952165 - Disclosure - Commitment and contingencies Sheet http://c4therapeutics.com/role/Commitmentandcontingencies Commitment and contingencies Notes 16 false false R17.htm 9952166 - Disclosure - Loss per share Sheet http://c4therapeutics.com/role/Losspershare Loss per share Notes 17 false false R18.htm 9952167 - Disclosure - Restructuring Sheet http://c4therapeutics.com/role/Restructuring Restructuring Notes 18 false false R19.htm 9952168 - Disclosure - Income taxes Sheet http://c4therapeutics.com/role/Incometaxes Income taxes Notes 19 false false R20.htm 9952169 - Disclosure - Segment reporting Sheet http://c4therapeutics.com/role/Segmentreporting Segment reporting Notes 20 false false R21.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 21 false false R22.htm 9955511 - Disclosure - Summary of significant accounting policies (Policies) Sheet http://c4therapeutics.com/role/SummaryofsignificantaccountingpoliciesPolicies Summary of significant accounting policies (Policies) Policies 22 false false R23.htm 9955512 - Disclosure - Fair value measurements (Tables) Sheet http://c4therapeutics.com/role/FairvaluemeasurementsTables Fair value measurements (Tables) Tables http://c4therapeutics.com/role/Fairvaluemeasurements 23 false false R24.htm 9955513 - Disclosure - Marketable securities (Tables) Sheet http://c4therapeutics.com/role/MarketablesecuritiesTables Marketable securities (Tables) Tables http://c4therapeutics.com/role/Marketablesecurities 24 false false R25.htm 9955514 - Disclosure - Property and equipment (Tables) Sheet http://c4therapeutics.com/role/PropertyandequipmentTables Property and equipment (Tables) Tables http://c4therapeutics.com/role/Propertyandequipment 25 false false R26.htm 9955515 - Disclosure - Accrued expenses and other current liabilities (Tables) Sheet http://c4therapeutics.com/role/AccruedexpensesandothercurrentliabilitiesTables Accrued expenses and other current liabilities (Tables) Tables http://c4therapeutics.com/role/Accruedexpensesandothercurrentliabilities 26 false false R27.htm 9955516 - Disclosure - Collaboration and license agreements (Tables) Sheet http://c4therapeutics.com/role/CollaborationandlicenseagreementsTables Collaboration and license agreements (Tables) Tables http://c4therapeutics.com/role/Collaborationandlicenseagreements 27 false false R28.htm 9955517 - Disclosure - Stock-based compensation (Tables) Sheet http://c4therapeutics.com/role/StockbasedcompensationTables Stock-based compensation (Tables) Tables http://c4therapeutics.com/role/Stockbasedcompensation 28 false false R29.htm 9955518 - Disclosure - Loss per share (Tables) Sheet http://c4therapeutics.com/role/LosspershareTables Loss per share (Tables) Tables http://c4therapeutics.com/role/Losspershare 29 false false R30.htm 9955519 - Disclosure - Segment reporting (Tables) Sheet http://c4therapeutics.com/role/SegmentreportingTables Segment reporting (Tables) Tables http://c4therapeutics.com/role/Segmentreporting 30 false false R31.htm 9955520 - Disclosure - Nature of the business and basis of presentation (Details) Sheet http://c4therapeutics.com/role/NatureofthebusinessandbasisofpresentationDetails Nature of the business and basis of presentation (Details) Details http://c4therapeutics.com/role/Natureofthebusinessandbasisofpresentation 31 false false R32.htm 9955521 - Disclosure - Fair value measurements (Details) Sheet http://c4therapeutics.com/role/FairvaluemeasurementsDetails Fair value measurements (Details) Details http://c4therapeutics.com/role/FairvaluemeasurementsTables 32 false false R33.htm 9955522 - Disclosure - Marketable securities - Summary of marketable securities (Details) Sheet http://c4therapeutics.com/role/MarketablesecuritiesSummaryofmarketablesecuritiesDetails Marketable securities - Summary of marketable securities (Details) Details 33 false false R34.htm 9955523 - Disclosure - Marketable securities - Narrative (Details) Sheet http://c4therapeutics.com/role/MarketablesecuritiesNarrativeDetails Marketable securities - Narrative (Details) Details 34 false false R35.htm 9955524 - Disclosure - Property and equipment (Details) Sheet http://c4therapeutics.com/role/PropertyandequipmentDetails Property and equipment (Details) Details http://c4therapeutics.com/role/PropertyandequipmentTables 35 false false R36.htm 9955525 - Disclosure - Accrued expenses and other current liabilities (Details) Sheet http://c4therapeutics.com/role/AccruedexpensesandothercurrentliabilitiesDetails Accrued expenses and other current liabilities (Details) Details http://c4therapeutics.com/role/AccruedexpensesandothercurrentliabilitiesTables 36 false false R37.htm 9955526 - Disclosure - Collaboration and license agreements - Narrative (Details) Sheet http://c4therapeutics.com/role/CollaborationandlicenseagreementsNarrativeDetails Collaboration and license agreements - Narrative (Details) Details 37 false false R38.htm 9955527 - Disclosure - Collaboration and license agreements - Summary of allocation of transaction price (Details) Sheet http://c4therapeutics.com/role/CollaborationandlicenseagreementsSummaryofallocationoftransactionpriceDetails Collaboration and license agreements - Summary of allocation of transaction price (Details) Details 38 false false R39.htm 9955528 - Disclosure - Collaboration and license agreements - Schedule of revenue from collaboration agreements (Details) Sheet http://c4therapeutics.com/role/CollaborationandlicenseagreementsScheduleofrevenuefromcollaborationagreementsDetails Collaboration and license agreements - Schedule of revenue from collaboration agreements (Details) Details 39 false false R40.htm 9955529 - Disclosure - Collaboration and license agreements - Schedule of financial information related to collaboration and license agreements (Details) Sheet http://c4therapeutics.com/role/CollaborationandlicenseagreementsScheduleoffinancialinformationrelatedtocollaborationandlicenseagreementsDetails Collaboration and license agreements - Schedule of financial information related to collaboration and license agreements (Details) Details 40 false false R41.htm 9955530 - Disclosure - Collaboration and license agreements - Schedule of supplemental financial information related to collaboration and license agreements (Details) Sheet http://c4therapeutics.com/role/CollaborationandlicenseagreementsScheduleofsupplementalfinancialinformationrelatedtocollaborationandlicenseagreementsDetails Collaboration and license agreements - Schedule of supplemental financial information related to collaboration and license agreements (Details) Details 41 false false R42.htm 9955531 - Disclosure - Stockholder's equity (Details) Sheet http://c4therapeutics.com/role/StockholdersequityDetails Stockholder's equity (Details) Details 42 false false R43.htm 9955532 - Disclosure - Stock-based compensation - Schedule of stock-based compensation expense (Details) Sheet http://c4therapeutics.com/role/StockbasedcompensationScheduleofstockbasedcompensationexpenseDetails Stock-based compensation - Schedule of stock-based compensation expense (Details) Details 43 false false R44.htm 9955533 - Disclosure - Stock-based compensation - Narrative (Details) Sheet http://c4therapeutics.com/role/StockbasedcompensationNarrativeDetails Stock-based compensation - Narrative (Details) Details 44 false false R45.htm 9955534 - Disclosure - Loss per share - Schedule of diluted net loss per share attributable to common stockholders (Details) Sheet http://c4therapeutics.com/role/LosspershareScheduleofdilutednetlosspershareattributabletocommonstockholdersDetails Loss per share - Schedule of diluted net loss per share attributable to common stockholders (Details) Details 45 false false R46.htm 9955535 - Disclosure - Loss per share - Schedule of basic and diluted loss per share (Details) Sheet http://c4therapeutics.com/role/LosspershareScheduleofbasicanddilutedlosspershareDetails Loss per share - Schedule of basic and diluted loss per share (Details) Details 46 false false R47.htm 9955536 - Disclosure - Restructuring (Details) Sheet http://c4therapeutics.com/role/RestructuringDetails Restructuring (Details) Details http://c4therapeutics.com/role/Restructuring 47 false false R48.htm 9955537 - Disclosure - Income taxes (Details) Sheet http://c4therapeutics.com/role/IncometaxesDetails Income taxes (Details) Details http://c4therapeutics.com/role/Incometaxes 48 false false R49.htm 9955538 - Disclosure - Segment reporting (Details) Sheet http://c4therapeutics.com/role/SegmentreportingDetails Segment reporting (Details) Details http://c4therapeutics.com/role/SegmentreportingTables 49 false false All Reports Book All Reports cccc-20250630.htm cccc-20250630.xsd cccc-20250630_cal.xml cccc-20250630_def.xml cccc-20250630_lab.xml cccc-20250630_pre.xml http://fasb.org/srt/2025 http://fasb.org/us-gaap/2025 http://xbrl.sec.gov/dei/2025 http://xbrl.sec.gov/ecd/2025 true true